Načítá se...
Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer
With a five-year survival rate under 9%, pancreatic ductal adenocarcinoma (PDAC) represents one of the deadliest tumors. Although the treatment options are slightly improving, PDAC is the second leading cause of cancer related death in 2020 in the US. In addition to a pronounced desmoplastic stroma...
Uloženo v:
| Vydáno v: | Cells |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7694089/ https://ncbi.nlm.nih.gov/pubmed/33113836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9112353 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|